Literature DB >> 9744435

Outpatient pacemaker procedures in orally anticoagulated patients.

D J Goldstein1, W Losquadro, H M Spotnitz.   

Abstract

Reexamination of surgical practices in the present era of cost containment has led to increased outpatient procedures including pacemaker surgery. While the safety and economic benefits of outpatient pacemaker surgery in nonanticoagulated patients is well documented, results of pacemaker operations in patients maintained on coumadin for thromboembolic prophylaxis have not been evaluated. In patients where complications with pacemaker surgery appeared successive, we have established a low incidence of complications. Recently, we extended this approach to the outpatient setting; this report retrospectively reviews our 4-year experience. During the study period, 150 patients underwent outpatient pacemaker procedures, including 37 patients receiving oral warfarin. There was no difference in the incidence of wound related and wound unrelated complications between patients receiving warfarin and the nonanticoagulated cohort. In addition, no wound hematomas, blood transfusions, or clinically significant bleeding episodes were noted among warfarin recipients. We conclude that pacemaker surgery in patients receiving oral anticoagulation is safe and feasible. The use of the cephalic cutdown technique avoiding blind subclavian punctures, meticulous attention to pocket hemostasis, and the use of small caliber unipolar positive fixation leads appears warranted in this selected group of patients at high risk for perioperative bleeding.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9744435     DOI: 10.1111/j.1540-8159.1998.tb00271.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  11 in total

Review 1.  Meta-analysis of bleeding complications associated with cardiac rhythm device implantation.

Authors:  Michael L Bernard; Matthew Shotwell; Paul J Nietert; Michael R Gold
Journal:  Circ Arrhythm Electrophysiol       Date:  2012-04-24

2.  Association of Uninterrupted Oral Anticoagulation During Cardiac Device Implantation with Pocket Hematoma.

Authors:  Brittany L Melton; Patricia A Howard; Abby Goerdt; Jessica Casey
Journal:  Hosp Pharm       Date:  2015-10-14

Review 3.  Perioperative management of antithrombotic therapy in patients receiving cardiovascular implantable electronic devices: a network meta-analysis.

Authors:  Hua He; Bing-Bing Ke; Yan Li; Fu-Sheng Han; Xiaodong Li; Yu-Jie Zeng
Journal:  J Interv Card Electrophysiol       Date:  2017-08-25       Impact factor: 1.900

4.  Chronic kidney disease is an independent predictor of pocket hematoma after pacemaker and defibrillator implantation.

Authors:  Imdad Ahmed; Elie Gertner; William B Nelson; Chad M House; Dennis W X Zhu
Journal:  J Interv Card Electrophysiol       Date:  2010-10-13       Impact factor: 1.900

5.  Periprocedural management of anticoagulation and antiplatelet therapies in patients undergoing electrophysiologic procedures.

Authors:  Jordana Kron; Daniel Alexander; Mark A Wood
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-10

6.  Safety of anticoagulation with uninterrupted warfarin vs. interrupted dabigatran in patients requiring an implantable cardiac device.

Authors:  Shivanshu Madan; Purushothaman Muthusamy; Katie L Mowers; Darryl A Elmouchi; Bohuslav Finta; Andre J Gauri; Alan K Woelfel; Timothy D Fritz; Alan T Davis; Nagib T Chalfoun
Journal:  Cardiovasc Diagn Ther       Date:  2016-02

7.  Antithrombotic or anti-platelet agents in patients undergoing permanent pacemaker implantation.

Authors:  Chang Kun Lee; Sang Yong Yoo; Man Yong Hong; Jin Kun Jang
Journal:  Korean Circ J       Date:  2012-08-31       Impact factor: 3.243

8.  A methodology to estimate the potential to move inpatient to one day surgery.

Authors:  Nicolas Gilliard; Yves Eggli; Patricia Halfon
Journal:  BMC Health Serv Res       Date:  2006-06-19       Impact factor: 2.655

Review 9.  Periprocedural antithrombotic therapy during various types of percutaneous cardiovascular interventions.

Authors:  P Widimský; V Kočka; F Roháč; P Osmančík
Journal:  Eur Heart J Cardiovasc Pharmacother       Date:  2015-12-11

10.  Preparation for pacemaker or implantable cardiac defibrillator implants in patients with high risk of thrombo-embolic events: oral anticoagulation or bridging with intravenous heparin? A prospective randomized trial.

Authors:  Jose M Tolosana; Paola Berne; Lluis Mont; Magda Heras; Antonio Berruezo; Joan Monteagudo; David Tamborero; Begoña Benito; Josep Brugada
Journal:  Eur Heart J       Date:  2009-05-31       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.